Calvelli Hannah, Kashem Mohammed Abul, Hanna Katherine, Azuma Masashi, Cheng Ke, Raman Ravishankar, Kehara Hiromu, Toyoda Yoshiya
Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA.
Surgery. 2025 Feb;178:108848. doi: 10.1016/j.surg.2024.09.010. Epub 2024 Oct 18.
Improvements in surgical techniques and perioperative care as well as increased patient life expectancies have led cardiothoracic surgeons to perform more complex operations, including reoperative open-heart surgeries. However, there is debate as to which patients are appropriate operative candidates for reoperative procedures.
This is a retrospective, single-center study of patients who underwent reoperative open-heart surgery via median sternotomy or thoracotomy over a 10-year period. Patients with previous ventricular assist device or heart transplant were excluded. Patients were stratified by age <65 years compared with age ≥65 years for analysis. Survival was assessed using Kaplan-Meier curves and log-rank tests. Multivariate analysis was performed with Cox proportional hazards regression.
A total of 250 patients underwent reoperative open-heart surgery at our center from 2012 to 2022. In total, 176 patients underwent valve surgery, 53 underwent coronary artery bypass grafting, 31 underwent aortic surgery, and 29 underwent other operations. The overall mortality rate was 13.6% at 30 days and 21.2% at 1-year postoperatively. Patients ≥65 years old had a greater average survival compared with patients <65 years old (5.0 vs 4.1 years, P = .046). However, there were no differences in survival by age when patients were stratified by procedure, either coronary artery bypass grafting (P = .29) or valve surgery (P = .16). On multivariate analysis, reoperative valve surgery, intraoperative use of extracorporeal membrane oxygenation, and a greater number of reoperative surgeries were associated with lower survival.
Patients undergoing reoperative open-heart surgery are clinically complex and had lower survival with each subsequent reoperation.
手术技术和围手术期护理的改进以及患者预期寿命的延长,促使心胸外科医生开展更复杂的手术,包括再次心脏直视手术。然而,对于哪些患者适合再次手术的候选者存在争议。
这是一项回顾性单中心研究,研究对象为在10年期间通过正中胸骨切开术或开胸术接受再次心脏直视手术的患者。排除既往使用心室辅助装置或心脏移植的患者。将患者按年龄<65岁与年龄≥65岁分层进行分析。使用Kaplan-Meier曲线和对数秩检验评估生存率。采用Cox比例风险回归进行多变量分析。
2012年至2022年期间,共有250例患者在本中心接受了再次心脏直视手术。其中,176例患者接受了瓣膜手术,53例接受了冠状动脉旁路移植术,31例接受了主动脉手术,29例接受了其他手术。术后30天的总死亡率为13.6%,术后1年为21.2%。≥65岁的患者平均生存期比<65岁的患者更长(5.0年对4.1年,P = 0.046)。然而,按手术方式分层时,无论是冠状动脉旁路移植术(P = 0.29)还是瓣膜手术(P = 0.16),患者的生存率在年龄方面均无差异。多变量分析显示,再次瓣膜手术、术中使用体外膜肺氧合以及更多的再次手术次数与较低的生存率相关。
接受再次心脏直视手术的患者临床情况复杂,每一次后续再次手术的生存率都会降低。